Podentamig Antibody
Podentamig is a bispecific VH-VH- (scFv-heavy -λ) format antibody targeting CD3 and TNFRSF17 (BCMA) . It is utilized in preclinical research for investigating T-cell redirection therapies against multiple myeloma, supporting both in vitro cytotoxicity assays and in vivo efficacy studies.
Product Specifications
Target
TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog